🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
Prospective, double-blind, randomized assessment of the efficacy, safety an...
Status
Completed
Location
Research Site 1
Start Date
2017-03-29
Trial ID
NCT03027609
The following issues warrant in-depth investigation: further refinement of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07279532
Treatments Being Tested
Cervical cancer is the most common cause of death from gynecological cancer...
Status
Active Not Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2019-05-01
Trial ID
NCT03955185
Treatments Being Tested
The purpose of this study is to examine whether a low dose of CBD+THC will ...
Status
Terminated
Location
University Hospital Campus, London Health Sciences Centre
Start Date
2019-01-10
Trial ID
NCT03808935
Treatments Being Tested
Novel approaches to improve TB treatment outcomes (to reduce morbidity, mor...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2016-09
Trial ID
NCT02781909
Treatments Being Tested
This multicenter, prospective, open-label randomized controlled trial with ...
Status
Not Yet Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2026-06-01
Trial ID
NCT07557485
Treatments Being Tested
This study will test the safety and effectiveness of the amino acid glycine...
Status
Completed
Location
National Institute of Mental Health (NIMH)
Start Date
2000-05
Trial ID
NCT00005658
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
Septic shock (SS) is a life-threatening condition resulting from excessive ...
Status
Recruiting
Location
Intensive Care Unit, University Hospital No 4,
Start Date
2023-01-09
Trial ID
NCT06225258
Treatments Being Tested